Ixoreal Biomed Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 31-10-2024
- Paid Up Capital ₹ 4.08 M
as on 31-10-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 327.94%
(FY 2023)
- Profit 432.13%
(FY 2023)
- Ebitda 36.33%
(FY 2023)
- Net Worth 2.31%
(FY 2023)
- Total Assets 2.11%
(FY 2023)
About Ixoreal Biomed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.08 M, as per Ministry of Corporate Affairs (MCA) records.
Mahesh Baldwa and Kartikeya Baldwa serve as directors at the Company.
- CIN/LLPIN
U85110TG2005PTC046201
- Company No.
046201
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationAbids Hyderabad, 001, Telangana
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ixoreal Biomed?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahesh Baldwa  | Director | 11-May-2005 | Current |
| Kartikeya Baldwa | Director | 01-Mar-2008 | Current |
Financial Performance of Ixoreal Biomed.
Ixoreal Biomed Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 327.94% increase. The company also saw a substantial improvement in profitability, with a 432.13% increase in profit. The company's net worth moved up by a moderate rise of 2.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ixoreal Biomed?
In 2023, Ixoreal Biomed had a public holding of 6.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skp Labs Private LimitedActive 28 years 8 monthsMahesh Baldwa and Kartikeya Baldwa are mutual person
- Ixoreal Biosciences Private LimitedActive 3 years 5 months
Mahesh Baldwa and Kartikeya Baldwa are mutual person
- Skyzoom Marketing Pvt.Ltd.Active 29 years 7 months
Mahesh Baldwa and Kartikeya Baldwa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ixoreal Biomed?
Unlock and access historical data on people associated with Ixoreal Biomed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ixoreal Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ixoreal Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
